CompletedNot Applicable

Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine S

South Korea238 participantsStarted 2022-09-21

Plain-language summary

This study in multi-center, prospective and observational study. The purpose of this study is to observe effects and safety of hyaluronic acid filler series, eptq S and eptq Lidocaine S, for facial volume and folds.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Wrinkle Severity Rating Scale score 3 or 4 for Nasolabial fold.
✓. Mid-Face Volume Deficit Scale score 3 or greater.
✓. Medicis Lip Fullness Scale score 1-2. In cases of 2-1) and 2-2), participants must meet both sides (right and left) to be eligible for enrollment.

What they're measuring

Nasolabial Folds

Timeframe: 24 weeks

Mid-Face Volume

Timeframe: 24 weeks

Lip Volume

Timeframe: 12 weeks

Trial details

NCT IDNCT06699147

SponsorJetema Co., Ltd.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-12-05

View on ClinicalTrials.gov More Nasolabial Folds trials